WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011143640) TREATMENT OF PAR4 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PAR4
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/143640    International Application No.:    PCT/US2011/036557
Publication Date: 17.11.2011 International Filing Date: 14.05.2011
IPC:
C12N 15/113 (2010.01), A61K 48/00 (2006.01), A61K 31/7088 (2006.01), C12N 15/63 (2006.01)
Applicants: CURNA, INC. [US/US]; 4400 Biscayne Blvd. Miami, Florida 33137 (US) (For All Designated States Except US).
COLLARD, Joseph [US/US]; (US) (For US Only).
KHORKOVA SHERMAN, Olga [US/US]; (US) (For US Only)
Inventors: COLLARD, Joseph; (US).
KHORKOVA SHERMAN, Olga; (US)
Agent: BROWDER, Monte R.; 4400 Biscayne Blvd. Miami, Florida 33137 (US)
Priority Data:
61/334,933 14.05.2010 US
Title (EN) TREATMENT OF PAR4 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO PAR4
(FR) TRAITEMENT DES MALADIES ASSOCIÉES À PAR4 PAR INHIBITION DU PRODUIT DE TRANSCRIPTION ANTISENS NATUREL DE PAR4
Abstract: front page image
(EN)The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of PAR4, in particular, by targeting natural antisense polynucleotides of PAR4. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of PAR4.
(FR)Cette invention concerne des oligonucléotides antisens qui modulent l'expression et/ou la fonction de PAR4, en particulier en ciblant les polynucléotides antisens naturels de PAR4. L'invention concerne également l'identification de ces oligonucléotides antisens et leur utilisation dans le traitement des maladies et des affections associées à l'expression de PAR4.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)